Taken together, PS341 enhanced the expression of FOXO3 in mRNA and protein levels in HCC and CRC cells, in which FOXO3 could bind to the promoter of CTNNB1 and suppressed the expression of CTNNB1. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.